Literature DB >> 7411167

Myoadenylate deaminase deficiency--muscle biopsy and muscle culture in a patient with gout.

S DiMauro, A F Miranda, A P Hays, W A Franck, G S Hoffman, R S Schoenfeldt, N Singh.   

Abstract

AMP deaminase activity was undetectable by a sensitive spectrophotometric assay in the muscle biopsy of a 37-year-old man with gout and exercise-related cramps and myalgia. Venous ammonia failed to rise after ischemic exercise, but the diagnostic value of this test is uncertain because changes of plasma ammonia after exercise varied greatly in different normal individuals. In the patient, AMP deaminase activity was normal not only in erythrocytes, leukocytes and cultured fibroblasts but also in muscle cultures. Presence of AMP deaminase in muscle cultures was probably due to the expression of a fetal isoenzyme under separate genetic control from adult muscle AMP deaminase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7411167     DOI: 10.1016/0022-510x(80)90003-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Muscle metabolism and red cell ATP/ADP concentration during bicycle ergometer in patients with AMPD-deficiency.

Authors:  D R Wagner; J Felbel; U Gresser; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-04-04

2.  Type 2a fibre rhabdomyolysis in myoadenylate deaminase deficiency.

Authors:  C Zimmer; H Altenkirch; S Dorfmüller-Küchlin; D Pongratz; I Paetzke; G Gosztonyi
Journal:  J Neurol       Date:  1991-02       Impact factor: 4.849

3.  Autosomal recessive distal myopathy.

Authors:  H Isaacs; M E Badenhorst; T Whistler
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

4.  Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency.

Authors:  M Gross; S Reiter; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-12-04

Review 5.  Molecular biology of AMP deaminase deficiency.

Authors:  M Gross
Journal:  Pharm World Sci       Date:  1994-04-15

6.  Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.

Authors:  R L Sabina; J L Swain; C W Olanow; W G Bradley; W N Fishbein; S DiMauro; E W Holmes
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

7.  Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency.

Authors:  C J Rebouche; A G Engel
Journal:  In Vitro       Date:  1982-05

8.  Myoadenylate deaminase deficiency in a patient with facial and limb girdle myopathy.

Authors:  R Mercelis; J J Martin; I Dehaene; T de Barsy; G Van den Berghe
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

9.  Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies.

Authors:  R Mercelis; J J Martin; T de Barsy; G Van den Berghe
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

10.  Myoadenylate deaminase deficiency with severe rhabdomyolysis.

Authors:  F A Baumeister; M Gross; D R Wagner; D Pongratz; R Eife
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.